Member Exclusive

Drugging the undruggable: targeting challenging E3 ligases for personalized medicine

This research article brought to MedChemNet users by our sister journal Future Medicinal Chemistry, discusses the challenges that surround attempting to target E3 ligases for personalized medicine.

Go to the profile of RxNet
Apr 25, 2017

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.